NCT05818423

Brief Summary

The purpose of this study is to develop and test a comprehensive Brain Health Together program for older adults living with cognitive decline.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
208

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Apr 2023

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 24, 2023

Completed
17 days until next milestone

Study Start

First participant enrolled

April 10, 2023

Completed
8 days until next milestone

First Posted

Study publicly available on registry

April 18, 2023

Completed
1.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 30, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 30, 2024

Completed
1.4 years until next milestone

Results Posted

Study results publicly available

April 29, 2026

Completed
Last Updated

April 29, 2026

Status Verified

April 1, 2026

Enrollment Period

1.6 years

First QC Date

March 24, 2023

Results QC Date

December 12, 2025

Last Update Submit

April 24, 2026

Conditions

Keywords

MemoryCognitive

Outcome Measures

Primary Outcomes (4)

  • Creyos Cognitive Composite - 3 Month

    The Creyos online cognitive test battery included digit span, feature match, grammatical reasoning, paired associates, and token search. We converted raw scores to standardized z scores for each test using the group baseline mean and standard deviation. We then summed the standardized scores to create a composite cognitive score and re-standardized the composite score using the group baseline mean and standard deviation (baseline mean=0, SD=1). Positive change reflects improved cognitive performance.

    Baseline to 3 months

  • Alzheimer's Disease Risk Index - Short Form-Change (ANU-ADRI-SF) - 3 Month Change

    This is a validated measure that combines validated component measures of individual dementia risk factors and also provides a summary dementia risk score. We created a modified version that only included risk factors that are modifiable and targeted by our intervention (depression, physical activity, cognitive activity, social isolation, alcohol consumption, smoking, and fish intake) using the weights from the original score. We then converted the calculated score to a z score using the group baseline mean and SD (baseline mean=0, SD=1). Positive change scores reflect increased dementia risk; negative scores reflect reduced dementia risk.

    Baseline to 3 months

  • Creyos Cognitive Composite - 6 Month Change

    The Creyos online cognitive test battery included digit span, feature match, grammatical reasoning, paired associates, and token search. We converted raw scores to standardized z scores for each test using the group baseline mean and standard deviation. We then summed the standardized scores to create a composite cognitive score and re-standardized the composite score using the group baseline mean and standard deviation (baseline mean=0, SD=1). Positive change reflects improved cognitive performance.

    Baseline to 6 months

  • Alzheimer's Disease Risk Index - Short Form-Change (ANU-ADRI-SF) - 6 Month Change

    This is a validated measure that combines validated component measures of individual dementia risk factors and also provides a summary dementia risk score. We created a modified version that only included risk factors that are modifiable and targeted by our intervention (depression, physical activity, cognitive activity, social isolation, alcohol consumption, smoking, and fish intake) using the weights from the original score. We then converted the calculated score to a z-score using the group baseline mean and SD (baseline mean=0, SD=1). Positive change scores reflect increased dementia risk; negative scores reflect reduced dementia risk.

    Baseline to 6 months

Secondary Outcomes (22)

  • Loneliness / Social Isolation - 3 Month Change

    Baseline to 3 months

  • Depression - 3 Month Change

    Baseline to 3 months

  • Cognitive Activity - 3 Month Change

    Baseline and 3 months

  • Physical Activity - 3 Month Change

    Baseline to 3 months

  • Emotional Well-being - 3 Month Change

    Baseline to 3 months

  • +17 more secondary outcomes

Study Arms (3)

Brain Health Academy

EXPERIMENTAL

Participants in this arm will watch expert videos on a wide range of brain health topics and will complete quizzes for 2.5 hours a week for 12 weeks (30 hours total)

Behavioral: Brain Health Academy

Brain Health Together

EXPERIMENTAL

Participants in this arm will participate in online, live-streaming Moving Together classes (1 hour a week) and group brain health classes (1 hour a week) and will work 1-on-1 with a brain health coach to set personalized risk reduction goals (0.5 hours a week) for 12 weeks (30 hours total)

Behavioral: Brain Health Together

Brain Health Together Plus

EXPERIMENTAL

Participants in this arm will participate in the full Brain Health Together program for 12 weeks (30 hours) followed by weekly group classes and six 1-on-1 coaching sessions for another 12 weeks (additional 15 hours; 45 hours total)

Behavioral: Maintain Brain Health Together

Interventions

The Brain Health Academy group will review online content about brain health (1 hour, 2 days/week for 12 weeks) and will complete a brief survey after each module to assess compliance (30 hours total).

Brain Health Academy

The Brain Health Together group will participate in online, live-streaming, group-based Moving Together classes (1 hour/week); Brain Health education group classes (1 hour/week) and individual brain health coaching sessions (0.5 hours/week) for 12 weeks (30 hours total).

Brain Health Together

The Maintaining Brain Health Together group will participate in the full Brain Health Together program (30 hours) for 12 weeks followed by weekly group classes and six individual coaching for an additional 12 weeks (additional 15 hours).

Brain Health Together Plus

Eligibility Criteria

Age55 Years - 85 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • English language fluency;\*
  • live in U.S.;
  • cognitive decline (subjective cognitive decline OR diagnosis of mild cognitive impairment in the past 12 months)
  • ready to make lifestyle changes to improve brain health;
  • have 2 or more brain health risk factors (e.g., low physical activity, depression, hypertension, diabetes, etc)
  • have a desktop or laptop computer or iPad/tablet with a video camera;
  • have broadband internet access;
  • able to participate in online, live-streaming classes with two-way video

You may not qualify if:

  • Alzheimer's disease or dementia
  • \- Major neurological disorder (e.g., Parkinson's disease, Multiple Sclerosis, amyotrophic Lateral Sclerosis)
  • Schizophrenia or other psychotic disorder
  • Autism or autism spectrum disorder
  • Major mood or anxiety disorder that is not well-controlled (e.g., symptoms of depression or anxiety that made it hard to do daily tasks in past 6 months)
  • Fracture of spine ("compression fracture") in the past 12 months
  • Vertigo or severe dizziness in the past 12 months
  • Severe vision or hearing impairment (e.g., unable to see and hear well enough to watch a movie on TV);
  • Stroke or heart attack in the past 12 months
  • Physical limitation that would restrict ability to participate (e.g., use wheelchair or walker to get around home, unable to stand up from sitting without assistance)
  • Currently in another research study that could confound results of this study (e.g., drug study or other study to improve brain health)
  • Previous participation in Moving Together or Brain Health Together
  • Limited life expectancy (e.g., enrolled in hospice, undergoing cancer treatment)
  • If participants are not sure about certain conditions, they will be asked to describe their condition, and the research team will determine whether they meet eligibility criteria or not.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of California, San Francisco

San Francisco, California, 94143, United States

Location

MeSH Terms

Conditions

Cognitive DysfunctionCognition DisordersLymphoma, Follicular

Condition Hierarchy (Ancestors)

Neurocognitive DisordersMental DisordersLymphoma, Non-HodgkinLymphomaNeoplasms by Histologic TypeNeoplasmsLymphoproliferative DisordersLymphatic DiseasesHemic and Lymphatic DiseasesImmunoproliferative DisordersImmune System Diseases

Results Point of Contact

Title
Deborah Barnes
Organization
University of California, San Francisco

Study Officials

  • Deborah Barnes, PhD

    Primary Investigator

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 24, 2023

First Posted

April 18, 2023

Study Start

April 10, 2023

Primary Completion

November 30, 2024

Study Completion

November 30, 2024

Last Updated

April 29, 2026

Results First Posted

April 29, 2026

Record last verified: 2026-04

Data Sharing

IPD Sharing
Will not share

Sharing permissions will be configured to ensure files containing PHI can only be accessed by authorized individuals. Two-step verification will be used as an additional safeguard against unauthorized access. Permissions will be updated when personnel roles change and they no longer need access to PHI or when they leave the research team.

Locations